Skip to content

Legal

Accessibility

Draft — subject to legal review

DRAFT — SUBJECT TO LEGAL REVIEW. This document has not been reviewed by legal counsel and is not yet in effect.

Last updated: October 2026 (draft)

1. Our Commitment

Object Pharma, Inc. is committed to making its website accessible to the widest possible audience, including people with disabilities. Our goal is for this website to conform to the Web Content Accessibility Guidelines (WCAG) 2.1 Level AA.

Accessibility is an ongoing effort, and we continue to review and improve the website as content and features evolve.

2. Measures We Take

Measures supporting accessibility on this website include semantic page structure, keyboard-navigable menus and controls, text alternatives for meaningful images, sufficient color contrast, and responsive layouts for different screen sizes and zoom levels.

3. Known Limitations

Some scientific animations and interactive visualizations may not be fully perceivable by all assistive technologies. We aim to provide equivalent text descriptions for essential scientific content wherever practicable.

4. Feedback

We welcome feedback on the accessibility of this website. If you encounter an accessibility barrier, please contact us through the contact form and describe the page and the issue you experienced. We will make reasonable efforts to address your concern.

5. Compatibility

This website is designed to be compatible with current versions of major browsers and commonly used assistive technologies.

The product candidates and development programs described on this website are investigational and have not been approved by the U.S. Food and Drug Administration or other regulatory authorities unless explicitly stated otherwise.